Sciclone Pharma (SCLN) Reports Q3 EPS of $0.24

November 9, 2016 5:04 PM EST
Get Alerts SCLN Hot Sheet
Trade SCLN Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Sciclone Pharma (NASDAQ: SCLN) reported Q3 EPS of $0.24, versus $0.26 reported last year. Revenue for the quarter came in at $40.5 million, versus $42.9 million reported last year.

For earnings history and earnings-related data on Sciclone Pharma (SCLN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment